Literature DB >> 22527503

Circulating endothelial cells and circulating endothelial progenitors.

Patrizia Mancuso1, Angelica Calleri, Francesco Bertolini.   

Abstract

The roles of circulating endothelial cells (CECs) and circulating endothelial progenitors (CEPs) are currently being investigated in several diseases including cancer and metastases development. Preclinical and clinical data suggest that CEC enumeration might be useful to identify patients who might benefit from anti-angiogenic treatments while CEPs seem to have a "catalytic" role in different steps of cancer progression and recurrence after therapy. The definition of CEC and CEP phenotypes and the standardization of CEC and CEP enumeration procedures are highly warranted to use these cells as biomarkers in clinical trials in oncology, and to compare results from different studies.

Entities:  

Mesh：

Year:  2012        PMID： 22527503     DOI： 10.1007/978-3-642-28160-0_14

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


  8 in total

1.  Circulating endothelial progenitor cells in castration resistant prostate cancer: a randomized, controlled, biomarker study.

Authors:  Thorsten Fuereder; Volker Wacheck; Sabine Strommer; Peter Horak; Marion Gerschpacher; Wolfgang Lamm; Danijel Kivaranovic; Michael Krainer
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

2.  Antitumor effects of CD40 ligand-expressing endothelial progenitor cells derived from human induced pluripotent stem cells in a metastatic breast cancer model.

Authors:  Yovita Ida Purwanti; Can Chen; Dang Hoang Lam; Chunxiao Wu; Jieming Zeng; Weimin Fan; Shu Wang
Journal:  Stem Cells Transl Med       Date:  2014-06-27       Impact factor: 6.940

3.  CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olaparib and Cediranib Compared with Olaparib in Recurrent Platinum-Sensitive Ovarian Cancer.

Authors:  Jung-Min Lee; Jane B Trepel; Peter Choyke; Liang Cao; Tristan Sissung; Nicole Houston; Minshu Yu; William D Figg; Ismail Baris Turkbey; Seth M Steinberg; Min-Jung Lee; S Percy Ivy; Joyce F Liu; Ursula A Matulonis; Elise C Kohn
Journal:  Front Oncol       Date:  2015-06-01       Impact factor: 6.244

4.  Circulating Tumor Cells: Who is the Killer?

Authors:  Patrizia Paterlini-Bréchot
Journal:  Cancer Microenviron       Date:  2014-12-20

5.  Prognostic value of circulating endothelial cells in metastatic colorectal cancer.

Authors:  Nuh N Rahbari; Sebastian Schölch; Ulrich Bork; Christoph Kahlert; Martin Schneider; Mohammad Rahbari; Markus W Büchler; Jürgen Weitz; Christoph Reissfelder
Journal:  Oncotarget       Date:  2017-06-06

6.  Circulating endothelial cells and procoagulant microparticles in patients with glioblastoma: prognostic value.

Authors:  Gaspar Reynés; Virtudes Vila; Tania Fleitas; Edelmiro Reganon; Jaime Font de Mora; María Jordá; Vicenta Martínez-Sales
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

7.  Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?

Authors:  Amin El-Heliebi; Thomas Kroneis; Evelyn Zöhrer; Johannes Haybaeck; Katja Fischereder; Karin Kampel-Kettner; Richard Zigeuner; Hannelore Pock; Regina Riedl; Rudolf Stauber; Jochen Bernd Geigl; Berthold Huppertz; Peter Sedlmayr; Carolin Lackner
Journal:  J Transl Med       Date:  2013-09-17       Impact factor: 5.531

8.  Cryopreservation and Enumeration of Human Endothelial Progenitor and Endothelial Cells for Clinical Trials.

Authors:  T Bogoslovsky; D Wang; D Maric; L Scattergood-Keepper; M Spatz; S Auh; J Hallenbeck
Journal:  J Blood Disord Transfus       Date:  2013-09-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.